Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析

◆英語タイトル:Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81774FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Tiziana Life Sciences Plc (TILS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical-stage biotechnology company that discovers and develops drugs to treat inflammatory diseases and cancers. The company’s lead product candidate, Milciclib (TZLS-201), intended for the treatment of thymic carcinoma. Its other clinical programs includes Foralumab (TZLS-401), a human engineered anti-human CD3 antibody intended for the treatment of Crohn’s disease and Nonalcoholic steatohepatitis. The company’s preclinical stage candidates include TZLS-501, a fully human anti-IL-6R monoclonal antibody targeting the interleukin-6 receptor; and StemPrintER, a multi-gene signature assay intended for the treatment of patients with breast cancer. Tiziana is headquartered in London, the UK.

Tiziana Life Sciences Plc Key Recent Developments

Aug 27,2020: Tiziana Life Sciences CEO updates shareholders on its patent portfolio, clinical pipeline, and strategy in an exclusive interview
Aug 20,2020: Tiziana is pleased to retain Dr. Napoleone Ferrara to serve on its Scientific Advisory Board for an additional three-year term
Jul 20,2020: Tiziana Life Sciences : Director appointment
Jun 18,2020: Tiziana Life Sciences directorate change
Jun 18,2020: Tiziana Life Sciences : Final results for the year ended 31 December 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Tiziana Life Sciences Plc – Key Facts
Tiziana Life Sciences Plc – Key Employees
Tiziana Life Sciences Plc – Key Employee Biographies
Tiziana Life Sciences Plc – Major Products and Services
Tiziana Life Sciences Plc – History
Tiziana Life Sciences Plc – Company Statement
Tiziana Life Sciences Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Tiziana Life Sciences Plc – Business Description
R&D Overview
Tiziana Life Sciences Plc – SWOT Analysis
SWOT Analysis – Overview
Tiziana Life Sciences Plc – Strengths
Tiziana Life Sciences Plc – Weaknesses
Tiziana Life Sciences Plc – Opportunities
Tiziana Life Sciences Plc – Threats
Tiziana Life Sciences Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Tiziana Life Sciences Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 27, 2020: Tiziana Life Sciences CEO updates shareholders on its patent portfolio, clinical pipeline, and strategy in an exclusive interview
Aug 20, 2020: Tiziana is pleased to retain Dr. Napoleone Ferrara to serve on its Scientific Advisory Board for an additional three-year term
Jul 20, 2020: Tiziana Life Sciences : Director appointment
Jun 18, 2020: Tiziana Life Sciences directorate change
Jun 18, 2020: Tiziana Life Sciences : Final results for the year ended 31 December 2019
Jan 21, 2020: Tiziana Life Sciences announces appointment of Mr. Gregor MacRae to strengthen the board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Tiziana Life Sciences Plc, Key Facts
Tiziana Life Sciences Plc, Key Employees
Tiziana Life Sciences Plc, Key Employee Biographies
Tiziana Life Sciences Plc, Major Products and Services
Tiziana Life Sciences Plc, History
Tiziana Life Sciences Plc, Other Locations
Tiziana Life Sciences Plc, Subsidiaries
Tiziana Life Sciences Plc, Key Competitors
Tiziana Life Sciences Plc, Ratios based on current share price
Tiziana Life Sciences Plc, Annual Ratios
Tiziana Life Sciences Plc, Annual Ratios (Cont...1)
Tiziana Life Sciences Plc, Interim Ratios
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Tiziana Life Sciences Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • Calamos Asset Management, Inc.
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bacardi Ltd:企業の戦略的SWOT分析
    Bacardi Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CorEnergy Infrastructure Trust Inc (CORR):企業の財務・戦略的SWOT分析
    CorEnergy Infrastructure Trust Inc (CORR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Acticor Biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that provides monoclonal antibody targeting solutions through platelet glyco …
  • Exxon Mobil Corporation:企業の戦略・SWOT・財務情報
    Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report Summary Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Jiangxi Copper Co Ltd:企業の戦略・SWOT・財務情報
    Jiangxi Copper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Jiangxi Copper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Altavia SA:企業の戦略的SWOT分析
    Altavia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Rockies Standard Oil Company LLC-石油・ガス分野:企業M&A・提携分析
    Summary Rockies Standard Oil Company LLC (RSOC) is an oil and gas service provider that offers exploration services for oil and gas projects in the Rockies. The company undertakes projects such as Overthrust and Hingeline, Utah and Southern Uinta and Paradox Basins, Utah. Its Southern Uinta and Para …
  • EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. …
  • Mitsui Oil Exploration Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Mitsui Oil Exploration Co., Ltd. (MOECO), a subsidiary of Mitsui & Co., Ltd, is an upstream oil and gas company. The company explores for, develops and produces oil, natural gas and condensate from its assets. It is also involved in a geothermal energy project. The company also holds investm …
  • W. L. Gore & Associates Inc:企業の製品パイプライン分析
    Summary W. L. Gore & Associates Inc (Gore) is a materials science company serving diverse industries. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company develops products for medical implants; fabr …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Leprino Foods Company:企業の戦略・SWOT・財務情報
    Leprino Foods Company - Strategy, SWOT and Corporate Finance Report Summary Leprino Foods Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • British Columbia Ferry Services Inc.:企業の戦略的SWOT分析
    British Columbia Ferry Services Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Infant Bacterial Therapeutics AB (IBT B)-製薬・医療分野:企業M&A・提携分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal i …
  • J D Wetherspoon plc (JDW):企業の財務・戦略的SWOT分析
    J D Wetherspoon plc (JDW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AIA Insurance Lanka Plc (CTCE.N0000):企業の財務・戦略的SWOT分析
    AIA Insurance Lanka Plc (CTCE.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆